Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study.

PubWeight™: 1.75‹?› | Rank: Top 3%

🔗 View Article (PMID 20129574)

Published in JACC Cardiovasc Interv on January 01, 2010

Authors

Francesco Pelliccia1, Cinzia Cianfrocca, Giuseppe Rosano, Giuseppe Mercuro, Giulio Speciale, Vincenzo Pasceri

Author Affiliations

1: Department of Cardiovascular Diseases, San Filippo Neri Hospital, Rome, Italy.

Articles citing this

Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol (2011) 1.32

Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent. Biomark Med (2011) 0.92

Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis. Eur Heart J (2012) 0.92

Positron emission tomography imaging of atherosclerosis. Theranostics (2013) 0.87

Understanding the role of endothelial progenitor cells in cardiovascular disease, coronary artery lesion progression, and in-stent restenosis. JACC Cardiovasc Interv (2010) 0.86

Angiotensin II-derived reactive oxygen species promote angiogenesis in human late endothelial progenitor cells through heme oxygenase-1 via ERK1/2 and AKT/PI3K pathways. Inflammation (2014) 0.84

Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells. Differentiation (2015) 0.84

The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access. PLoS One (2014) 0.82

Circulating hematopoietic and endothelial progenitor cells in newborn infants: effects of gestational age, postnatal age and clinical stress in the first 3 weeks of life. Early Hum Dev (2013) 0.80

Higher numbers of circulating endothelial progenitor cells in stroke patients with intracranial arterial stenosis. BMC Neurol (2013) 0.76

Percutaneous coronary intervention causes a rapid but transient mobilisation of CD34(+)CD45(-) cells. Open Heart (2014) 0.76

Association between microalbuminuria predicting in-stent restenosis after myocardial infarction and cellular senescence of endothelial progenitor cells. PLoS One (2015) 0.75

CXCR7/p-ERK-Signaling Is a Novel Target for Therapeutic Vasculogenesis in Patients with Coronary Artery Disease. PLoS One (2016) 0.75

Endothelial progenitor cells and plaque burden in stented coronary artery segments: an optical coherence tomography study six months after elective PCI. BMC Cardiovasc Disord (2017) 0.75

CD34 affinity pheresis attenuates a surge among circulating progenitor cells following vascular injury. J Vasc Surg (2013) 0.75

The relationship between the number of preprocedural circulating endothelial progenitor cells and angiographic restenosis following coronary artery stent placement. Heart Asia (2011) 0.75

INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial. Trials (2012) 0.75

Articles by these authors

Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation (2006) 3.62

Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation (2005) 3.25

Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. J Am Coll Cardiol (2009) 2.85

Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol (2007) 2.66

Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation (2005) 2.49

Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J (2007) 2.38

Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies. Circulation (2011) 2.34

Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Arch Intern Med (2012) 2.09

Cardiopulmonary and endothelial effects of metformin treatment in an insulin resistant population. Int J Cardiol (2012) 2.03

Endothelial progenitor cells predict long-term prognosis in patients with stable angina treated with percutaneous coronary intervention: five-year follow-up of the PROCREATION study. Circ J (2013) 2.02

Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation. J Cardiovasc Med (Hagerstown) (2011) 1.99

Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ Res (2008) 1.76

Ultrasound tissue characterization detects preclinical myocardial structural changes in children affected by Duchenne muscular dystrophy. J Am Coll Cardiol (2003) 1.72

Comparison of access-related bleeding complications in women versus men undergoing percutaneous coronary catheterization using the radial versus femoral artery. Am J Cardiol (2007) 1.57

Clinical effects of routine postdilatation of drug-eluting stents. Catheter Cardiovasc Interv (2013) 1.49

Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial. Eur Heart J (2010) 1.49

Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial. J Am Coll Cardiol (2010) 1.47

Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women. J Cardiovasc Med (Hagerstown) (2009) 1.44

Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty. Catheter Cardiovasc Interv (2010) 1.43

Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel. Catheter Cardiovasc Interv (2010) 1.41

The effect of sex/gender on cardiovascular pharmacology. Curr Pharm Des (2011) 1.41

Early beneficial effects of drug-eluting stents in vein grafts wane during long term follow-up: a case-control study. Catheter Cardiovasc Interv (2012) 1.41

An old drug for use in the prevention of sudden infant unexpected death due to vagal hypertonia. Eur J Pediatr (2011) 1.39

Three-year results of repaired Barlow mitral valves via right minithoracotomy versus median sternotomy in a randomized trial. Cardiology (2014) 1.38

Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study. J Sex Med (2010) 1.31

Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial. Am J Cardiol (2011) 1.17

Rapid recruitment of temporally distinct vascular gene sets by estrogen. Mol Endocrinol (2008) 1.16

Immunoregulation through extracellular nucleotides. Blood (2012) 1.14

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). J Cachexia Sarcopenia Muscle (2010) 1.10

Muscle wasting disease: a proposal for a new disease classification. J Cachexia Sarcopenia Muscle (2014) 1.10

Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. Am J Cardiol (2007) 1.10

A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure. J Am Coll Cardiol (2012) 1.08

Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. J Am Coll Cardiol (2006) 1.08

Body weight-supported high-intensity locomotor training and adapted physical activity program in patients with Parkinson's disease: a complementary approach? Arch Phys Med Rehabil (2013) 1.06

Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study. Cardiovasc Diabetol (2003) 1.05

Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study). Am J Cardiol (2009) 1.05

Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways. Arterioscler Thromb Vasc Biol (2011) 1.04

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail (2013) 1.04

Regular cigarette smoking influences the transsulfuration pathway, endothelial function, and inflammation biomarkers in a sex-gender specific manner in healthy young humans. Am J Transl Res (2013) 1.03

Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment. Am Heart J (2010) 1.02

Comparison of the feasibility and effectiveness of transradial coronary angiography via right versus left radial artery approaches (from the PREVAIL Study). Am J Cardiol (2012) 1.01

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome. Cardiovasc Diabetol (2005) 0.98

Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol (2007) 0.98

Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response. Circulation (2003) 0.98

Can a chronic dental infection be considered a cause of cardiovascular disease? A review of the literature. Int J Cardiol (2010) 0.95

Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther (2011) 0.94

Evidence of cocaine-related coronary atherosclerosis in young patients with myocardial infarction. J Am Coll Cardiol (2006) 0.94

Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol (2007) 0.93

Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study). Am J Cardiol (2011) 0.93

Platelet-derived growth factor receptor beta-subtype regulates proliferation and migration of gonocytes. Endocrinology (2008) 0.92

Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol (2005) 0.91

Cell sex determines anoikis resistance in vascular smooth muscle cells. FEBS Lett (2009) 0.91

Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention. Am J Cardiol (2013) 0.91

The heart and the gut. Eur Heart J (2013) 0.91

Tai chi enhances the effects of endurance training in the rehabilitation of elderly patients with chronic heart failure. Rehabil Res Pract (2010) 0.90

Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study. J Am Coll Cardiol (2011) 0.90

The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes. FEBS J (2013) 0.90

Metabolic syndrome, abdominal obesity, and cardiovascular risk in elderly women. Int J Cardiol (2006) 0.90

Regulation of collateral blood vessel development by the innate and adaptive immune system. Trends Mol Med (2012) 0.90

Oral contraceptives modify DNA methylation and monocyte-derived macrophage function. Biol Sex Differ (2012) 0.89

Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression. Autoimmun Rev (2010) 0.89

Exercise-induced skeletal muscle remodeling and metabolic adaptation: redox signaling and role of autophagy. Antioxid Redox Signal (2014) 0.89

Association of laryngeal cancer with previous gastric resection. Ann Surg (2004) 0.89

In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy. Ital Heart J (2003) 0.89

Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects. Cardiovasc Diabetol (2013) 0.88

Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients. J Card Fail (2011) 0.88

Cor triatriatum and lipomatous hypertrophy of the interatrial septum in the elderly: a case report. Cardiovasc Ultrasound (2010) 0.88

Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study. Int J Cardiol (2012) 0.88

Optimization of the atrioventricular delay in sequential and biventricular pacing: physiological bases, critical review, and new purposes. Europace (2012) 0.88

Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation. Diabetes Care (2012) 0.88

Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers. Oncologist (2008) 0.88

Identifying factors that predict the choice and success rate of radial artery catheterisation in contemporary real world cardiology practice: a sub-analysis of the PREVAIL study data. EuroIntervention (2010) 0.88

Matched dose interval and continuous exercise training induce similar cardiorespiratory and metabolic adaptations in patients with heart failure. Int J Cardiol (2012) 0.87

Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data. J Sex Med (2011) 0.87

Steps forward in regulatory pathways for acute and chronic heart failure. Eur J Heart Fail (2015) 0.87

ATP secreted by endothelial cells blocks CX₃CL 1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y₁₁ receptor activation. Blood (2010) 0.87

Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations. Muscle Nerve (2010) 0.87

Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction. Exp Ther Med (2011) 0.86

C-reactive protein and left atrial appendage velocity are independent determinants of the risk of thrombogenesis in patients with atrial fibrillation. Int J Cardiol (2009) 0.86

Evaluation of regional myocardial function by Doppler tissue imaging in univentricular heart after successful Fontan repair. Echocardiography (2010) 0.86

High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study. J Am Coll Cardiol (2011) 0.85

Gender disparity in susceptibility to oxidative stress and apoptosis induced by autoantibodies specific to RLIP76 in vascular cells. Antioxid Redox Signal (2011) 0.85

Cell surface estrogen receptor alpha is upregulated during subchronic metabolic stress and inhibits neuronal cell degeneration. PLoS One (2012) 0.85

Increased arterial stiffness in children with Williams syndrome and normal blood pressure. Blood Press Monit (2010) 0.85

Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study). Am J Cardiol (2012) 0.84

Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol (2005) 0.83

Distal left circumflex coronary artery flow reserve recorded by transthoracic Doppler echocardiography: a comparison with Doppler-wire. Cardiovasc Ultrasound (2007) 0.83

Effect of High-Intensity interval training versus moderate continuous training on 24-h blood pressure profile and insulin resistance in patients with chronic heart failure. Intern Emerg Med (2013) 0.83

Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease. Int J Cardiol (2009) 0.82

Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties. Eur J Heart Fail (2013) 0.82

Increased arterial rigidity in children affected by Cushing's syndrome after successful surgical cure. Cardiol Young (2010) 0.82

Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis. Int J Cardiol (2013) 0.82

Dose-response relationship of baroreflex sensitivity and heart rate variability to individually-tailored exercise training in patients with heart failure. Int J Cardiol (2011) 0.82